Marc Braunstein

988 total citations
47 papers, 539 citations indexed

About

Marc Braunstein is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Marc Braunstein has authored 47 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 17 papers in Molecular Biology and 9 papers in Genetics. Recurrent topics in Marc Braunstein's work include Multiple Myeloma Research and Treatments (26 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers). Marc Braunstein is often cited by papers focused on Multiple Myeloma Research and Treatments (26 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers). Marc Braunstein collaborates with scholars based in United States, United Kingdom and Türkiye. Marc Braunstein's co-authors include Mary Lee‐Wong, Jonathan I. Silverberg, G. P. Wormser, Deborah A. Levy, Stine Knudsen, Brad Dworkin, Roman Jankowski, Olcay Batuman, Pamela B. Davis and Gareth J. Morgan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Marc Braunstein

35 papers receiving 524 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marc Braunstein United States	11	196	125	99	99	69	47	539
Marta Martínez‐Bonet Spain	14	130 0.7×	75 0.6×	57 0.6×	64 0.6×	176 2.6×	27	593
Momoyo Azuma Japan	14	143 0.7×	34 0.3×	71 0.7×	50 0.5×	65 0.9×	34	605
Lee Ct Taiwan	15	155 0.8×	66 0.5×	90 0.9×	175 1.8×	169 2.4×	44	698
Alejandra King Chile	16	167 0.9×	41 0.3×	73 0.7×	126 1.3×	93 1.3×	31	607
Mònica Arman United Kingdom	12	110 0.6×	171 1.4×	81 0.8×	86 0.9×	42 0.6×	18	837
Jean-François Balavoine Switzerland	8	88 0.4×	35 0.3×	58 0.6×	52 0.5×	64 0.9×	27	492
Suzanne Samarani Canada	17	209 1.1×	70 0.6×	74 0.7×	159 1.6×	78 1.1×	34	861
Paul L. Black United States	13	141 0.7×	43 0.3×	68 0.7×	74 0.7×	79 1.1×	27	467
Sarah M. Hicks Australia	10	68 0.3×	60 0.5×	48 0.5×	52 0.5×	26 0.4×	23	402
Samuel Antwi‐Baffour Ghana	16	444 2.3×	68 0.5×	50 0.5×	82 0.8×	73 1.1×	39	745

Countries citing papers authored by Marc Braunstein

Since Specialization

Citations

This map shows the geographic impact of Marc Braunstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Braunstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Braunstein more than expected).

Fields of papers citing papers by Marc Braunstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Braunstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Braunstein. The network helps show where Marc Braunstein may publish in the future.

Co-authorship network of co-authors of Marc Braunstein

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Braunstein. A scholar is included among the top collaborators of Marc Braunstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Braunstein. Marc Braunstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Usmani, Saad Z., Thierry Façon, Vânia Hungria, et al.. (2025). Efficacy of Daratumumab-Bortezomib-Lenalidomide-Dexamethasone (DVRd) vs Daratumumab-Lenalidomide-Dexamethasone (DRd) in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma (NDMM). Clinical Lymphoma Myeloma & Leukemia. 25. S308–S308.

Islam, Shahidul, et al.. (2024). Characterization and Comparative Outcomes of Younger Multiple Myeloma Patients. Blood. 144(Supplement 1). 5155–5155.

Bashir, Qaiser, Marc Braunstein, Murali Janakiram, et al.. (2023). Overcoming Barriers to Autologous Stem Cell Transplantation in Multiple Myeloma: Recommendations from a Multidisciplinary Roundtable Discussion. Transplantation and Cellular Therapy. 29(11). 666–673. 7 indexed citations

Braunstein, Marc, Patrick Blaney, & Gareth J. Morgan. (2023). Whole-Genome Sequencing Identifies Structural Variation As a Key Driver of Disease Relapse and Aggressive Clinical Behavior in Multiple Myeloma. Blood. 142(Supplement 1). 2773–2773. 1 indexed citations

Islam, Shahidul, et al.. (2023). Association of food insecurity with reduced cancer screening rates.. Journal of Clinical Oncology. 41(16_suppl). e18609–e18609. 3 indexed citations

Islam, Shahidul, et al.. (2023). Young and Distinct: Clinical Characteristics and Outcomes of Patients 50 or Younger with Multiple Myeloma. Blood. 142(Supplement 1). 6684–6684.

Islam, Shahidul, et al.. (2022). Outcomes of Patients With Hematologic Malignancies Who Received Inpatient Palliative Care Consultation. JCO Oncology Practice. 18(5). e688–e696. 5 indexed citations

Miller, Erin, et al.. (2022). Hemoglobin Alpha Chain Variant Zara Associated With Familial Asymptomatic Hypoxemia. Journal of Hematology. 11(5). 190–195.

Braunstein, Marc, Louis Williams, David Kaminetzky, et al.. (2022). Inflammation and infection in plasma cell disorders: how pathogens shape the fate of patients. Leukemia. 36(3). 613–624. 17 indexed citations

10.

Ashby, Cody, Eileen M. Boyle, Michael Bauer, et al.. (2022). Structural variants shape the genomic landscape and clinical outcome of multiple myeloma. Blood Cancer Journal. 12(5). 85–85. 10 indexed citations

11.

Boyle, Eileen M., Patrick Blaney, Yubao Wang, et al.. (2021). Unifying the Definition of High-Risk in Multiple Myeloma. Blood. 138(Supplement 1). 2714–2714.

12.

Maura, Francesco, Eileen M. Boyle, Even H Rustad, et al.. (2021). Chromothripsis as a pathogenic driver of multiple myeloma. Seminars in Cell and Developmental Biology. 123. 115–123. 25 indexed citations

13.

Grossbard, Michael L., et al.. (2021). Characterization of Second Primary Malignancies in Mucosa-Associated Lymphoid Tissue Lymphomas: A SEER Database Interrogation.. Clinical Lymphoma Myeloma & Leukemia. 22(2). 76–81. 4 indexed citations

14.

Schneider, Jeffrey C., et al.. (2020). Considerations for the Management of Oncology Patients During the COVID-19 Pandemic. PubMed. 34(3410). 432–441. 3 indexed citations

15.

Bannoudi, Hanane El, C. Anquetil, Marc Braunstein, Sergei L. Kosakovsky Pond, & Gregg J. Silverman. (2017). Unbiased RACE-Based Massive Parallel Surveys of Human IgA Antibody Repertoires. Methods in molecular biology. 1643. 45–73. 7 indexed citations

16.

Braunstein, Marc & Rubén Niesvizky. (2016). Deferring autologous stem cell transplantation for consolidation of minimal residual disease in multiple myeloma. Seminars in Oncology. 43(6). 709–711. 3 indexed citations

17.

Silverberg, Jonathan I., Marc Braunstein, & Mary Lee‐Wong. (2014). Association between climate factors, pollen counts, and childhood hay fever prevalence in the United States. Journal of Allergy and Clinical Immunology. 135(2). 463–469.e5. 55 indexed citations

18.

Braunstein, Marc, Tayfun Özçelık, Sevgi Baǧışlar, et al.. (2006). Endothelial progenitor cells display clonal restriction in multiple myeloma. BMC Cancer. 6(1). 161–161. 10 indexed citations

19.

Dworkin, Brad, G. P. Wormser, Stine Knudsen, et al.. (1985). Gastrointestinal manifestations of the acquired immunodeficiency syndrome: a review of 22 cases.. PubMed. 80(10). 774–8. 157 indexed citations

20.

Braunstein, Marc, et al.. (1971). Interest of freshman medical students in family practice.. PubMed. 67(10). 435–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact